This document is an excerpt from the EUR-Lex website
Document 01998A0421(01)-20060310
Agreement between the European Community and the United States of America on sanitary measures to protect public and animal health in trade in live animals and animal products
Consolidated text: Agreement between the European Community and the United States of America on sanitary measures to protect public and animal health in trade in live animals and animal products
Agreement between the European Community and the United States of America on sanitary measures to protect public and animal health in trade in live animals and animal products
ELI: http://data.europa.eu/eli/agree_internation/1998/258/2006-03-10
01998A0421(01) — EN — 10.03.2006 — 001.001
This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document
|
AGREEMENT (OJ L 118 21.4.1998, p. 3) |
Amended by:
|
|
|
Official Journal |
||
|
No |
page |
date |
||
|
L 316 |
21 |
29.11.2003 |
||
|
L 137 |
33 |
31.5.2005 |
||
|
L 71 |
12 |
10.3.2006 |
||
AGREEMENT
between the European Community and the United States of America on sanitary measures to protect public and animal health in trade in live animals and animal products
THE EUROPEAN COMMUNITY,
of the one part, and
THE GOVERNMENT OF THE UNITED STATES OF AMERICA,
of the other part,
DESIRING to safeguard public and animal health and to facilitate trade in animals and animal products between the European Community (hereinafter referred to as ‘the Community’) and the United States of America (hereinafter referred to as ‘the USA’);
RESOLVED to take the fullest account of the risk of spread of animal diseases and the measures put in place to control and eradicate such diseases, and in particular to avoid disruptions to trade;
REAFFIRMING their commitment to the rights and obligations established under the World Trade Organisation Agreement on the application of sanitary and phytosanitary measures (hereinafter referred to as the ‘SPS Agreement’);
WHEREAS the Parties acknowledge that their systems of sanitary measures are intended to address similar objectives of providing comparable health assurances;
NOTING that the recognition by an importing country of the sanitary measures applied by an exporting country can permit greater efficiency in the utilisation of inspection and verification resources;
HAVE DECIDED to conclude this Agreement and to this end have designated respectively as their plenipotentiaries:THE EUROPEAN COMMUNITY
THE GOVERNMENT OF THE UNITED STATES OF AMERICA
WHO HAVE AGREED AS FOLLOWS:
Article 1
Objective
The objective of this Agreement is to facilitate trade in live animals and animal products between the Community and the USA by establishing a mechanism for the recognition of equivalence of sanitary measures maintained by a Party consistent with the protection of public and animal health, and to improve communication and cooperation on sanitary measures.
Article 2
Multilateral obligations
Nothing in this Agreement shall limit the rights or obligations of the Parties under the Agreement establishing the World Trade Organisation and its Annexes, in particular the SPS Agreement.
Article 3
Scope
Article 4
Regulatory authorities
Article 5
Definitions
For the purposes of this Agreement the following definitions shall apply:
‘sanitary measures’ means sanitary measures as defined in Annex A, paragraph 1, of the SPS Agreement and falling within the scope of this Agreement. The reference to sanitary measures may cover individual sanitary measures or groups of sanitary measures for product areas, sectors, or parts of sectors, as appropriate;
‘appropriate level of sanitary protection’ means the appropriate level of sanitary protection as defined in Annex A, paragraph 5, of the SPS Agreement;
‘region’ means zones or regions as defined in the Animal Health Code of the Office international des epizooties (OIE), and for aquaculture as defined in the International Aquatic Animal Health Code of the OIE;
‘Agreement’ means the entire text of this Agreement and all its Annexes.
Article 6
Animal health status
The exporting Party shall, if requested by the importing Party, provide full explanation and supporting data for the determinations and decisions covered by this Article. The importing Party may, where necessary for the protection of animal health, invoke the provisions of Article 12.
Article 7
Equivalence
In reaching a determination whether a sanitary measure maintained by an exporting Party achieves the importing Party's appropriate level of sanitary protection, the Parties shall follow a consultative process that includes the following steps:
identification of the sanitary measure for which recognition of equivalence is sought;
explanation by the importing Party of the objective of its sanitary measure, including an assessment, as appropriate to the circumstances, of the risk or risks, that the sanitary measure is intended to address, and identification by the importing Party of its appropriate level of sanitary protection;
demonstration by the exporting party that its sanitary measure achieves the importing Party's appropriate level of sanitary protection;
determination by the importing party whether a sanitary measure achieves its appropriate level of sanitary protection after consideration of various factors, including where appropriate:
risks identified by the importing Party and evidence provided by the exporting Party that its sanitary measures effectively address those risks;
provisions of the exporting Party's legislation and regulations regarding standards, procedures, policies, infrastructure, enforcement and control;
powers of the exporting Party's regulatory authorities and their structure, including their chain of command, modus operandi, and resources;
evidence provided by the exporting Party of the efficacy of its enforcement and control programmes.
The importing Party may carry out verification, as set out in Article 9, to assist this determination.
Article 8
Status of consultations
With respect to sanitary measures recognised as equivalent for trade purposes at the date of entry into force of this Agreement, each Party, within its responsibilities, shall initiate the necessary legislative and administrative actions within three months to implement these recognitions. For sanitary measures that will be recognised as equivalent in the future, each Party shall take prompt and necessary steps to implement the recognitions.
Where the trade conditions specified in Annex V include special conditions required by the importing Party to meet its appropriate level of protection, trade shall take place where the exporting Party meets the importing Party's conditions, without prejudice to the continuing consultative process.
Article 9
Verification provisions
In addition to carrying out checks on imports at the external frontier, the importing Party may verify compliance with the provisions of this Agreement through the application of procedures which may include, but are not limited to:
an assessment of all or part of the exporting Party's total control programme, including, where appropriate, reviews of the exporting Party's inspection and audit programmes, and
on-site checks and inspections.
On the mutual consent of the Parties to this Agreement, either Party may:
share the results and conclusions of its verification procedures with countries that are not parties to this Agreement, or
use the results and conclusions of verification procedures carried out by countries that are not parties to this Agreement.
Article 10
Information exchange
In addition to information on changes in sanitary measures, or to change existing sanitary measures, the Parties shall also exchange information on other relevant topics including:
Article 11
Notification
Each Party shall notify the other:
immediately by oral communication followed within 24 hours in writing: of any serious or significant public or animal health risk, notably including any food control emergencies or situations where there is a clearly identified risk of serious health effects associated with the consumption of animal products;
within 24 hours in writing: of the presence or evolution of any disease listed in Annex III;
without delay and in writing: of any significant changes in animal health status or of findings of epidemiological importance with respect to diseases other than those listed in Annex III; of changes in preventive policies, including vaccination policies; or, of any non-routine measures taken to protect public health or to control or eradicate animal disease.
Article 12
Safeguards
Either Party may take provisional measures necessary for the protection of public or animal health. These measures shall be notified within 24 hours to the other Party, and, on request, consultations regarding the situation shall be held within 14 days. The Parties shall take due account of any information provided through such consultations, and shall endeavour to avoid unnecessary disruption to trade, taking advantage where possible of the provisions of Article 11(3).
Article 13
Outstanding issues
The principles of this Agreement shall also be applied to address outstanding issues listed in Annex VIII. Modifications shall be made to this Annex and, as appropriate, other Annexes, to take account of progress made and new issues identified.
Article 14
Joint Management Committee
When additional expertise is needed, the Parties may also establish ad hoc technical working groups, notably scientific groups, whose membership need not be restricted to representatives of the Parties.
Article 15
Territorial application
This Agreement shall apply, on the one hand, to the territories in which the Treaty establishing the European Community is applied and under the conditions laid down in that Treaty, and on the other hand, to the United States of America in respect of its entire territory.
Article 16
Final provisions
This Agreement shall enter into force on the first day of the month following the date on which the Parties notify each other that the procedures mentioned in the preceding subparagraph have been completed.
###OLPI###signat=b###OGPI######OLPI###?tpl=-46mm###OGPI###For the For the Government of the
###OLPI###?tpl=-70mm###OGPI###European Community United States of America
Annexes
|
ANNEX I |
Product coverage |
|
ANNEX II |
Regulatory authorities |
|
ANNEX III |
List of diseases for which regional freedom is recognised |
|
ANNEX IV |
Zoning and regionalisation |
|
ANNEX V |
Recognition of sanitary measures |
|
ANNEX VI |
Guidelines for conducting an audit |
|
ANNEX VII |
Frontier checks |
|
ANNEX VIII |
Outstanding issues |
|
ANNEX IX |
Contact points |
ANNEX I
PRODUCT COVERAGE
|
Tariff line |
General description (1) |
|
01 |
Live animals |
|
02 |
Meat and edible meat offal |
|
03 |
Fish and crustaceans, molluscs and other aquatic invertebrates |
|
04 |
Dairy produce; birds' eggs; natural honey; edible products of animal origin not elsewhere specified or included |
|
05 |
Products of animal origin, not elsewhere specified or included, except for products of human origin |
|
1501 |
Lard; other pig and poultry fat, rendered |
|
1502 |
Fats of bovine animals, sheep or goats |
|
1503 |
Lard stearin, lard oil, oleostearin, oleo-oil and tallow oil |
|
1504 |
Fats and oils and their fractions, of fish and marine mammals |
|
1505 |
Wool grease and fatty substances derived there from (including lanolin) |
|
1506 |
Other animal fats and oils and their fractions |
|
1516 10 |
Animal fats and oils and their fractions |
|
1517 |
Margarine; edible mixtures or preparations of animal or vegetable fats or oils, except for such products consisting solely of vegetable fats or oils or their fractions |
|
1518 |
Animal or vegetable fats and oils; inedible mixtures or preparations of animal or vegetable fats or oils or of fractions of different fats or oils of Chapter 15, not elsewhere specified or included, except for such products consisting solely of vegetable fats or oils or their fractions |
|
1522 |
Degras; residues resulting from the treatment of fatty substances or animal or vegetable waxes, except for such products consisting solely of material of non-animal origin |
|
16 |
Preparations of meat, of fish or of crustaceans, molluscs or other aquatic invertebrates |
|
1702 10 |
Lactose and lactose syrup |
|
1901 |
Malt extract; food preparations of flour, meal, starch or malt extract; food preparations of goods of heading Nos 0401 to 0404, not elsewhere specified or included; except for such products consisting solely of material of non-animal origin |
|
1902 |
Pasta, whether or not cooked or stuffed (with meat or other substances) or otherwise prepared; couscous, whether or not prepared; except such products consisting solely of products of non-animal origin |
|
2104 |
Soups and broths and preparations therefor; homogenised composite food preparations; except such products consisting solely of products of non-animal origin |
|
2105 |
Ice cream and other edible ice, whether or not containing cocoa; except such products consisting solely of products of non-animal origin |
|
2106 |
Food preparations not elsewhere specified or included; except such products consisting solely of products of non-animal origin |
|
2301 |
Flours, meals and pellets, of meat or meat offal, of fish or of crustaceans, molluscs or other aquatic invertebrates, unfit for human consumption; greaves; except such products consisting solely of products of non-animal origin |
|
2309 |
Preparations of a kind used in animal feeding; except such products consisting solely of products of non-animal origin |
|
3001 |
Glands and other organs for organo-therapeutic uses; heparin and its salts; other animal substances prepared for therapeutic or prophylactic uses; except such products of human origin |
|
3002 |
Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products |
|
3101 |
Animal or vegetable fertilisers, except such products consisting solely of products of non-animal origin |
|
3501 |
Casein, caseinates and other casein derivatives; casein glues |
|
3502 |
Albumins, albuminates and other albumin derivatives |
|
3503 |
Gelatin and gelatin derivatives; isinglass; other glues of animal origin, excluding casein glues of heading No 3501 |
|
3504 |
Peptones and their derivatives; other protein substances and their derivatives, not elsewhere specified or included; hide powder, whether or not chromed |
|
3507 |
Enzymes; except such products consisting solely of products of non-animal origin |
|
4101 |
Raw hides and skins of bovine or equine animals |
|
4102 |
Raw skins of sheep or lambs |
|
4103 |
Other raw hides or skins |
|
4301 |
Raw furskins |
|
5101 |
Wool |
|
5102 |
Fine or coarse animal hair |
|
5103 |
Waste of wool or of fine or coarse animal hair |
|
5105 |
Wool and fine or coarse animal hair |
|
9705 |
Collections and collectors' pieces of zoological interest |
|
(1)
For definitive description refer to tariff code. |
|
ANNEX II
REGULATORY AUTHORITIES
A. UNITED STATES OF AMERICA
I. USA CONTROL AUTHORITY
The federal agencies listed in this section are responsible for both domestically-produced and imported animal products, unless otherwise noted.
In relation to imports into the USA, these agencies are responsible for:
In relation to exports from the USA, unless otherwise noted, these agencies are responsible for:
A. Control of animal health
1. Animal diseases/pests
Live animals (including apiculture bees), embryos, ova, semen and animal products — US Department of Agriculture/Animal and Plant Health Inspection Service (USDA/APHIS).
Imports of salmonid live fish, gametes and fertilised ova — Department of Interior/Fish and Wildlife Service (DOI/FWS).
Imports of uneviscerated salmonid fish — DOI/FWS.
Animal feed (including pet foods)
Transmission of disease from feed — USDA/APHIS.
Adulteration, pesticides, chemical and microbial contamination, food additives, substances ‘generally recognised as safe’ — Food and Drug Administration (FDA).
B. Control of public health
1. Meat and poultry for human consumption
Fresh meat and products from domesticated, farmed and wild cattle, sheep, swine, goats and equine — US Department of Agriculture/Food Safety and Inspection Service (USDA/FSIS) ( 1 )
Fresh meat and products from domestic and farmed chickens, turkeys, ducks, geese, and guinea fowl — USDA/FSIS ( 2 ).
Fresh meat and products from wild and farmed game, with the exception of those from IB1(a) and IB1(b) above — (FDA).
Fresh meat and products from species other than above — FDA.
Enforcing adulteration provisions of the law and limits for residues of drugs, pesticides, heavy metals, mycotoxins, and other contaminants in food:
sampling of fresh meat and animal products and control of the fresh meat and products from domesticated, farmed and wild cattle, sheep, swine, goats, and equine, and for domesticated and farmed chickens (including liquid, frozen and dried egg products), turkeys, ducks, geese, and guinea fowl — USDA/FSIS;
sampling of fresh meat and animal products (including animal feed) and control of the fresh meat and products of other species — FDA.
2. Eggs and egg products
Shell eggs, hard-cooked eggs, ethnic egg delicacies, and imitation egg products — FDA.
Shell eggs (including cracks and dirties) for breaking for the production of liquid, frozen, and dried egg products (egg yolks, albumen, or any combination) — USDA/FSIS ( 3 ).
3. Dairy
All dairy products — FDA.
4. Other animal-derived foods (including fish and fishery products)
All other animal-derived foods — FDA.
5. Animal feed
Adulteration, pesticides, chemical and microbial contamination, food additives, substances ‘generally recognised as safe’ — FDA.
II. COMPETENT AUTHORITIES FOR VOLUNTARY PROGRAMMES
The federal agencies listed in this section are responsible for voluntary inspection and certification programmes for domestically-produced animal products.
In relation to exports from the USA, these agencies are responsible for:
A. Animal health
Non-salmonid fish and other non-mammalian aquatic animals, gametes and fertilised ova — USDA/APHIS, Department of Commerce/National Marine Fisheries Service (Commerce/NMFS).
Salmonid live fish, gametes, and fertilised ova — USDA/APHIS, Commerce/NMFS.
Animal feed (including pet foods) containing fish and fishery products — USDA/APHIS, Commerce/NMFS.
B. Public health
Fresh meat and meat products ( 4 ) from wild and farmed bison, ostrich, emu, rhea, rabbit, deer, partridge, and quail — USDA/FSIS.
Snakes for human consumption — Commerce/NMFS.
Shell eggs — USDA/AMS.
Cooked omelets made from egg products, diced eggs made from egg products — USDA/FSIS.
Dairy — USDA/AMS.
Seafood (including live seafood) — Commerce/NMFS.
III. FEDERAL AGENCIES THAT ISSUE CERTIFICATION
This section lists the USA national agencies that issue export certificates agreed to by the EC and the USA ( 5 ). The agency issuing certificates may be the control authority or another national agency that is recognised by the control authority for that purpose. More than one agency may issue certificates for a product.
|
|
DOC/NMFS |
DOI/FWS |
FDA |
USDA/AMS |
USDA/APHIS |
USDA/FSIS |
|
A. Animal health certifications |
||||||
|
1. Live animals (including apiculture bees), embryos, ova, semen, and products of animal origin |
|
|
|
|
× |
|
|
2. Non-salmonid fish and other non-mammalian aquatic animals, gametes and fertilised ova |
× |
|
|
|
× |
|
|
3. Salmonid live fish, gametes, and fertilised ova |
× |
× |
|
|
× |
|
|
4. Wild waterfowl |
|
× |
|
|
|
|
|
5. Animal feed |
× |
|
|
|
× |
|
|
B. Public health certifications |
||||||
|
1. Meat and poultry for human consumption |
||||||
|
(a) Fresh meat and products from domesticated, farmed and wild cattle, sheep, swine, goats, and equine, and domesticated and farmed chickens, turkeys, ducks, geese, and guinea fowl |
|
|
|
|
|
× |
|
(b) Snakes |
× |
|
× |
|
|
|
|
(c) Fresh meat and products from species other than above |
|
|
× |
|
|
× |
|
2. Eggs |
||||||
|
(a) Shell eggs, hard cooked eggs, ethnic egg delicacies, and imitation egg products |
|
|
× |
× |
|
|
|
(b) Liquid, frozen and dried egg products |
|
|
|
|
|
× |
|
3. Dairy |
||||||
|
(a) Butter, cheese, frozen desserts, and dried milk products |
|
|
× |
× |
|
|
|
(b) Fluid milk |
|
|
× |
|
|
|
|
4. Seafood |
||||||
|
(a) Fish and fishery products including fish oil, reptiles (except snakes), snails and amphibians |
× |
|
× |
|
|
|
|
(b) Live fish (including shellfish and molluscs) |
× |
|
× |
|
|
|
B. EUROPEAN COMMUNITY
Control is shared between the national services in the individual Member States and the European Commission. In this respect the following applies:
ANNEX III
LIST OF DISEASES FOR WHICH REGIONAL FREEDOM IS RECOGNISED
Animal diseases
Aquaculture diseases
The list of aquaculture diseases is to be discussed further by the Parties on the basis of the International Aquatic Animal Health Code of the OIE.
ANNEX IV
ZONING AND REGIONALISATION
The Parties have jointly determined that the following forms the basis for regionalisation decisions for the diseases listed in accordance with Annex III. Each Party will recognise regionalisation decisions taken in accordance with the standard contained within this Annex.
Animal diseases
In assessing risk from a given proposed importation of animals or animal products, three sets of factors may be considered:
Source risk factors
Commodity risk factors
Destination risk factors
Source risk factors
The primary determinant of the risk of importing disease is the status of the country of origin in respect of the disease in question. However, declarations of disease freedom must be backed up by effective surveillance programmes.
The overriding consideration in this context, therefore, is the quality of the veterinary infrastructure. No other factors can be assessed without full confidence in the veterinary administration. In particular, its ability to detect and control an outbreak of disease and to provide meaningful certification is crucial.
The ability to detect the presence of disease depends on the surveillance carried out. This surveillance can be active, passive, or both.
Active surveillance implies definitive action intended to identify the presence of disease, such as systematic clinical inspections, ante and post mortem examination, serology on farm or in abattoir, referral of pathological material for laboratory diagnosis, sentinel animals.
Passive surveillance means that the disease must be compulsorily notifiable and that there must be a sufficiently high level of supervision of the animals in order to ensure that the disease will be observed quickly and reported as a suspect. There must also be a mechanism for investigation and confirmation, and a high level of awareness of the disease and its symptoms by farmers and veterinarians.
Epidemio-surveillance may be augmented by voluntary and compulsory herd/flock health programmes, particularly those which ensure a regular veterinary presence on the farm.
Other factors to be considered include:
On the basis of these factors, a zone may be defined.
The authority with the responsibility for implementing the zoning policy is in the best position to define and maintain the zone. When there is a high level of confidence in that authority, the decisions it makes can be the basis for trade.
The zones so defined may be assigned a risk category.
Possible categories are:
Calculation of estimates of risk for, for example, live animals may assist in this categorisation. Import conditions may then be defined for each category, disease and commodity, individually or in groups.
Low/negligible risk implies that importation may take place based on a simple guarantee of origin.
Medium risk implies that some combination of certification and/or guarantees may be required before or after importation.
High risk implies that importation will only take place under conditions which significantly reduce the risk, for example by additional guarantees, testing or treatment.
Unknown risk implies that importation will only take place if the commodity itself is of very low risk, for example hides, wool, or under the conditions for ‘high risk’ if the commodity factors warrant.
Commodity risk factors
These include:
Appropriate tests and quarantine will reduce the risk.
Destination risk factors
These factors are inherent in, or are under the control of the importing country, and some may therefore be modified to facilitate trade. These may, for example, include restricted entry conditions, for example animals to be confined to a certain vector free region until the incubation period has passed, or canalisation systems.
However, destination risk factors will also be taken into account by the infected country with respect to the risk presented by movements from the infected part to the free part of its territory.
Aquaculture diseases
Pending the development of any specific provisions to be included in this Annex, the basis for regionalisation decisions for aquaculture diseases will be the International Aquatic Animal Health Code of the OIE.
ANNEX V
RECOGNITION OF SANITARY MEASURES
|
Yes (1) |
The importing Party agrees that the exporting Party's measures achieve the importing Party's appropriate level of sanitary protection. |
|
Yes (2) |
The importing Party agrees that the exporting Party's measures, with the special conditions set out, achieve the importing Party's appropriate level of sanitary protection. |
|
Yes (3) |
Equivalence agreed in principle, subject to satisfactory completion of the actions. Pending completion, trade shall occur on the basis of the special conditions set out. |
|
NE |
Not evaluated. Trade shall occur on the basis of compliance with the importing Party's requirements. |
|
E |
Still evaluating. Trade shall occur on the basis of compliance with the importing Party's requirements. |
|
AI |
Avian influenza |
|
ASF |
African swine fever |
|
BSE |
Bovine spongiform encephalopathy |
|
CEM |
Contagious equine metritis |
|
CFR |
Code of Federal Regulations |
|
CSF |
Classical swine fever (hog cholera) |
|
EBL |
Enzootic bovine leucosis |
|
EC |
European Community |
|
EPIA |
Egg Products Inspection Act |
|
FFDCA |
Federal Food, Drug and Cosmetics Act |
|
FIFRA |
Federal Insecticide, Fungicide and Rodenticide Act |
|
FMD |
Food and mouth disease |
|
IBR |
Infectious bovine rhinotracheitis |
|
ND |
Newcastle disease |
|
OIE |
Office International des Epizooties |
|
PHSA |
Public Health Service Act |
|
PM |
Post mortem |
|
ScVC |
Scientific Veterinary Committee |
|
SVD |
Swine vesicular disease |
|
TB |
Bovine tuberculosis |
|
TME |
Transmissible mink encephalopathy |
|
TSE |
Transmissible spongiform encephalopathy |
|
USA |
United States of America |
|
WTO |
World Trade Organisation |
|
— Commodity — Species — Animal/public health |
European Community exports to the United States |
United States exports to the European Community |
||||||||
|
Trade conditions |
Equiv. (Cat.) |
Special conditions |
Actions |
Trade conditions |
Equiv. (Cat.) |
Special conditions |
Actions |
|||
|
EC standards |
US standards |
US standards |
EC standards |
|||||||
|
1. Live animals |
||||||||||
|
Animal health |
||||||||||
|
— Equidae |
90/426 Annexes B and C |
9 CFR 92 |
E |
|
EC to submit for each EC laboratory the testing procedures, antigens/reagents used, audit/quality control programme, external control/laboratory approval programme. Inter-laboratory reference testing and exchange of samples between designated EC and US laboratories for CEM, glanders, dourine, piroplasmosis, equine infectious anaemia and equine viral arteritis to be carried out within three months of the entry into force of this Agreement. US to consider, within five months of the entry into force of this Agreement, withdrawing requirement for post-import quarantine on the bases of results. US to assess EC request on disease status for dourine and glanders within three months of EC submission. US to review their CEM and piroplasmosis requirements within three months of the entry into force of this Agreement. |
9 CFR 71, 75, 91 |
90/426 92/260 93/195 93/196 93/197 94/467 |
E |
|
US to consider identifying horses by passport from 31.12.1997. EC to consider withdrawing requirement for isolation before departure for permanent imports within six months of the submission of the final report on VS outbreak. |
|
— Bovine animals |
64/432 72/462 90/425 |
9 CFR 92 |
E |
|
US to review BSE policy with respect to high and low incidence. US to produce generic conditions for EC. |
9 CFR 71, 72, 73, 77, 78, 80, 91 |
72/462 |
E |
|
EC to review US dossier on bluetongue. US to provide details of RB51 brucellosis vaccine, for review by EC. EC to produce conditions for US. |
|
— Sheep/goats |
91/68 |
9 CFR 92 |
E |
|
US to produce generic conditions for EC. |
9 CFR 54, 71, 79, 77 |
91/68 97/231 |
E |
|
EC to review US dossier on bluetongue. US to submit scrapie programme when final review is completed. EC to comment. EC to produce conditions for US. |
|
— Swine |
64/432 72/462 90/425 |
9 CFR 92 |
E |
|
US to produce generic conditions for EC. |
9 CFR 71, 76, 77, 78, 85 |
72/462 |
E |
|
EC to produce conditions for US. |
|
— Dogs and cats |
92/65 |
9 CFR 92 |
NE |
|
|
|
92/65 |
NE |
|
|
|
— ‘Balai’ animals |
92/65 |
9 CFR 92 |
NE |
|
|
|
92/65 |
NE |
|
|
|
2. Live poultry and hatching eggs |
||||||||||
|
Animal health |
||||||||||
|
|
90/539 93/342 |
9 CFR 92 |
E |
|
US to produce generic conditions. |
9 CFR 71, 82, 145, 147 |
90/539 93/432 96/482 96/483 |
E |
|
|
|
3. Semen |
||||||||||
|
Animal health |
||||||||||
|
— Bovine |
88/407 |
9 CFR 98 |
E |
|
US to produce generic conditions for EC. |
9 CFR 71, 77, 78 |
88/407 94/577 |
E |
|
EC to produce conditions to allow use of new elisa test kit for bluetongue. EC to consider allowing movement between centres in two approved third countries. |
|
— Sheep/goats |
92/65 |
9 CFR 98 |
E |
|
US to produce generic conditions for EC. |
9 CFR 71, 79 |
Directive 92/65 |
NE |
|
|
|
— Porcine |
90/429 |
9 CFR 98 |
E |
|
US to produce generic conditions for EC. |
9 CFR 71, 78, 85 |
90/429 93/199 |
E |
|
EC to examine US request that CSF tests not be required on entry and exit from centres in countries free of the disease. |
|
— Canine |
92/65 |
9 CFR 98 |
NE |
|
|
|
92/65 |
NE |
|
|
|
— Feline |
92/65 |
|
NE |
|
|
|
92/65 |
NE |
|
|
|
4. Equine semen, ova and embryos |
||||||||||
|
Animal health |
||||||||||
|
— Semen |
92/65 95/307 |
9 CFR 98 |
NE |
|
|
9 CFR 71, 75 |
92/65 96/539 |
NE |
|
|
|
— Ova |
92/65 95/294 |
9 CFR 98 |
NE |
|
|
9 CFR 71, 75 |
92/65 96/540 |
NE |
|
|
|
— Embryos |
92/65 95/294 |
9 CFR 98 |
NE |
|
|
9 CFR 71, 75 |
92/65 96/540 |
NE |
|
|
|
5. Embryos |
||||||||||
|
Animal health |
||||||||||
|
— Bovine |
89/556 |
9 CFR 98 |
E |
|
US to produce generic conditions for EC. US to review suspension of imports from BSE affected countries. |
9 CFR 71, 77, 78 |
89/556 92/471 |
E |
|
|
|
— Ovine/caprine |
92/65 |
9 CFR 98 |
NE |
|
|
|
92/65 |
NE |
|
|
|
6. Fresh meat |
||||||||||
|
Animal health |
||||||||||
|
— Ruminants |
64/432 72/461 72/462 |
9 CFR 94 |
Yes 2 |
Additional certification for bovines from BSE affected countries |
US to review rules on BSE with respect to high/low incidence regions |
9 CFR 53 (in the case of an outbreak of exotic disease) |
72/462 82/426 |
Yes 2 |
Three month residence Holding freedom from brucellosis for ovines and caprines |
|
|
— Equidae |
64/432 72/461 72/462 |
9 CFR 94 |
Yes 1 |
|
|
9 CFR 53 |
72/462 82/426 |
Yes 2 |
Three month residence |
|
|
— Porcine animals |
64/432 72/461 72/462 |
9 CFR 94 |
Yes 1 |
|
|
9 CFR 53 |
72/462 82/426 |
Yes 2 |
Three month residence Holding freedom from brucellosis |
|
|
Public health |
||||||||||
|
Ruminants (8) Equidae Porcine Ovine Caprine Ruminants (8) Equidae Porcine Ovine Caprine (cont’d) |
64/433 96/22 96/23 |
9 CFR 301-381, 416, 417 |
Yes 3 |
Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnote (1) Testing for Enterobacteriaceae and total viable count carried out as per Decision 2001/471/EC of 8 June 2001, except that: — random sampling must be carried out throughout the slaughter period — the four sample collection sites for cattle, swine, sheep, goats and horses cannot be changed from those specified in Decision 2001/471/EC of 8 June 2001 |
Equivalency (Yes 2) shall be granted after the US has completed verification of veterinary delivery systems This process shall be completed within 12 months of the date of entry into force of this Agreement |
9 CFR 301-381, 416, 417 |
72/462 93/158 96/22 96/23 |
Yes 3 |
Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnotes (2), (3), (4) and (5) |
The EC shall evaluate the US residue programme, and additional information to be submitted by the US, to determine whether it meets the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement The EC shall evaluate the US water standards to determine whether they meet the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement. The EC to evaluate a US request, when submitted, on the need for continued trichinae testing of horsemeat. Regarding footnote 5(e), the results of the inspections after incision of pig hearts shall be jointly evaluated after 12 months, with a view to determining if modifications should be made to the provisions of footnote 5(e). Equivalency (Yes 2) shall be granted after the EC has completed verification of the application of the specified conditions. This process shall be completed within 12 months of the entry into force of this Agreement. |
|
7. Poultry meat |
||||||||||
|
Animal health |
91/494 94/438 |
9 CFR 94 |
Yes 1 |
|
|
9 CFR 53 |
91/494 93/342 94/984 |
Yes 1 |
|
|
|
Public health |
71/118 96/22 96/23 |
9 CFR 381 |
Yes 3 |
Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnote (1). Post-mortem inspection to be carried out by official inspectors. |
Equivalency (Yes 2) shall be granted after the US has completed verification of veterinary delivery systems. This process shall be completed within 12 months of the date of entry into force of the Agreement. |
9 CFR 381.1—381.5 |
71/118 96/22 96/23 96/712 |
Yes 3 |
Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnotes (2), (3), (4) and (6). |
The EC shall evaluate the US residue programme, and additional information to be submitted by the US to determine whether it meets the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement. The EC shall evaluate the US water standards to determine whether they meet the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement. The EC shall carry out a scientific review of the use of antimicrobial techniques, and in particular the use of TSP and/or organic acids, with full participation of US scientists. The scientific review should be completed as soon as possible. Equivalency (Yes 2) shall be granted after the EC has completed verification of the application of the specified conditions. This process shall be completed within 12 months of the entry into force of this Agreement. |
|
8. Meat products |
||||||||||
|
Animal health |
||||||||||
|
— Red meat (ruminants/equidae) |
64/432 72/461 72/462 80/215 |
9 CFR 94 |
Yes 2 |
Additional certification for bovines from BSE affected countries. |
US to review rules on BSE with respect to high/low incidence regions. |
9 CFR 53 |
72/462 97/221 |
Yes 2 |
Derived from meat meeting the conditions of point 6 (fresh meat). |
|
|
— Pigs |
64/432 72/461 72/462 80/215 |
9 CFR 94 |
Yes 1 |
|
|
9 CFR 53 |
72/462 97/221 |
Yes 2 |
Derived from meat meeting the conditions of point 6 (fresh meat). |
|
|
— Poultry |
92/118 72/462 80/215 94/438 |
9 CFR 94 |
Yes 1 |
|
|
9 CFR 53 |
97/221 |
Yes 2 |
Derived from meat meeting the conditions of point 7 (poultry meat). |
|
|
— Wild game and farmed game |
92/495 92/45 |
9 CFR 94 |
Yes 2 |
Additional certification for bovines from BSE affected countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
92/495 92/45 97/221 |
NE |
|
|
|
Public health |
||||||||||
|
Ruminants (8) Equidae Pigs Poultry |
77/99 96/22 96/23 |
CFR 301—335, 354, 381.1—381.500 |
Yes 3 |
Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnote (1). |
Equivalency (Yes 2) shall be granted after the US has completed verification of veterinary delivery systems. This process shall be completed within 12 months of the date of entry into force of this Agreement. |
9 CFR 301—335, 354, 381.1—381.500 |
72/462 77/99 92/118 96/22 96/23 |
Yes 3 |
Derived from meat meeting the conditions of point 6 (fresh meat) and/or 7 (poultrymeat). Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnotes (2), (3) and (4). |
The EC shall evaluate the US residue programme, and additional information to be submitted by the US, to determine whether it meets the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement. The EC shall evaluate the US water standards to determine whether they meet the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement. Equivalency shall be granted after the EC has completed verification of the application of the specified conditions. This process shall be completed within 12 months of the entry into force of this Agreement. |
|
Wild game (8) Farmed game (8) |
77/99 96/22 96/23 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 113, 114, 170—189, 510—529, 556 40 CFR 180, 185 |
NE |
Existing trade conditions. |
|
FFDCA, FIFRA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 113, 114, 170—189, 510—529, 556 40 CFR 180, 185 |
77/99 92/118 96/22 96/23 |
NE |
|
|
|
9. Farmed game meat |
||||||||||
|
Animal health |
||||||||||
|
— Deer — Rabbit |
72/461 92/118 91/495 |
9 CFR 94 |
Yes 2 Yes 1 |
Additional certification from BSE affected countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
92/118 91/495 97/219 |
NE |
|
|
|
— Porcine |
72/461 92/118 91/495 |
9 CFR 94 |
Yes 1 |
|
|
|
92/118 |
NE |
|
|
|
— Feathered |
92/118 72/462 80/215 94/438 |
9 CFR 94 |
Yes 1 |
|
|
9 CFR 94 |
92/118 97/219 |
NE |
|
|
|
Public health |
||||||||||
|
See footnote (8) for ruminants |
91/495 96/22 96/23 97/219 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 113, 170—189, 510—529, 556 40 CFR 180, 185 9 CFR 301—335, 352, 354 |
NE |
Existing trade conditions. |
|
FFDCA, FIFRA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 113, 170—189, 510—529, 556 40 CFR 180, 185 9 CFR 301—335, 352, 354 |
91/495 96/22 96/23 97/219 |
NE |
|
|
|
10. Wild game meat |
||||||||||
|
Animal health |
||||||||||
|
— Deer — Rabbit |
92/45 |
9 CFR 94 |
E |
|
|
|
92/45 97/218 |
NE |
|
|
|
— Porcine |
92/45 |
9 CFR 94 |
E |
|
|
|
92/45 97/220 |
NE |
|
|
|
— Feathered |
92/45 |
9 CFR 94 |
E |
|
|
|
92/45 97/218 |
NE |
|
|
|
Public health |
||||||||||
|
See footnote (8) for ruminants |
92/45 96/22 96/23 97/218 97/220 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 170—189, 510—529, 556 9 CFR 301—335 40 CFR 180, 185 |
NE |
Existing trade conditions. |
|
FFDCA, FIFRA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 170—189, 510—529, 556 9 CFR 301—335 40 CFR 180, 185 |
92/45 96/22 96/23 97/218 97/220 |
NE |
|
|
|
11. Fisheries products for human consumption |
||||||||||
|
Animal health |
||||||||||
|
— Fish/fisheries products |
91/67 |
USDI & Title 50 |
NE |
|
|
USDI & Title 50 |
91/67 |
NE |
|
EC to evaluate new US standards if applicable. |
|
— Bivalve molluscs/crustaceans (excl. live) |
91/67 |
USDI & Title 50 |
NE |
|
|
USDI & Title 50 |
91/67 |
NE |
|
|
|
Public health |
||||||||||
|
— Fish/fisheries products |
91/493 96/22 96/23 |
21 CFR 123, 1240 FFDCA, FIFRA, PHSA, 21 CFR 70-82, 180, 110.3-110.93, 113, 114, 123, 172-193, 1240 |
Yes 3 |
Low-acid canned food requirement. |
US to provide a detailed indication of how the EC request for equivalence for low-acid canned food can be considered. EC to provide (1) appropriate information and documentation on procedures for audit and control of implementation by Member States, and (2) information on application of HACCP systems in Member States. |
21 CFR 123, 1240 FFDCA, FIFRA, PHSA, 21 CFR 70-82, 180, 110.3-110.93, 113, 114, 123, 172-193, 1240 |
91/493 96/22 96/23 |
Yes 2 |
[SANCO/10169/2005] Rev 3 |
|
|
— Fish/fisheries products (cont’d) |
|
|
|
|
US to conduct on-site verification of EC system (including visit to EC central offices and observation of Commission audits of a number of Member States). US to indicate any outstanding problems following above actions. The outcome of the on-site verification to be discussed with EC. If on-site verification satisfactory, the equivalence determination to be finalised, and any necessary procedures carried out. |
NMFS Voluntary HACCP based programme 50 CFR 260 |
|
Yes 1 |
|
|
|
— Bivalve molluscs/crustaceans (excl. live) |
91/492 |
National shellfish sanitation programme |
Yes 3 |
Existing trade conditions. |
EC to supply the raw data used for the scientific assessment on flesh/water testing. US shall respond to results of scientific assessment within 90 days of receipts of raw data. EC to provide (1) appropriate information and documentation on procedures for audit and control of implementation by Member States, and (2) information on application of HACCP systems in Member States. US to conduct on-site verification of EC system (including visit to EC central offices and observation of Commission audits of a number of Member States). US to indicate any outstanding problems following above actions. The outcome of the on-site verification to be discussed with EC. If on-site verification satisfactory, the equivalence determination to be finalised, and any necessary procedures carried out. |
National shellfish sanitation programme |
91/492 |
Yes 3 |
Existing trade conditions. |
Joint comparison of flesh/water testing for classification of production areas. US to inform the EC when the US is ready to have the implementation of its seafood HACCP Regulation reviewed. EC to carry out review, involving as necessary examination of information and documentation to be provided by US on procedures for audit and control of implementation. On-site verification of US system to be carried out within six months of US request. EC to indicate any outstanding problems following above actions within 45 days of on-site verification. The outcome of the on-site verification to be discussed with EC. If on-site verification satisfactory, the equivalence determination to be finalised, and any necessary procedures carried out. ‘Establishments’ do not include ‘brokers or traders’. |
|
— Aquaculture animals and products |
91/493 96/22 96/23 |
National shellfish sanitation programme, FFDCA, FIFRA, PHSA, 21 CFR 110.3-110.93, 123, 1240, DVM |
NE |
|
|
National shellfish sanitation programme, FFDCA, FIFRA, PHSA, 21 CFR 110.3-110.93, 123, 1240, DVM |
91/493 96/22 96/23 |
NE |
|
|
|
12. Live fish/shellfish and gametes |
||||||||||
|
Animal health |
91/67 |
|
NE |
|
|
|
91/67 |
NE |
|
|
|
13. Milk and milk-based products for human consumption |
||||||||||
|
Animal health |
||||||||||
|
— Cattle including buffalo — Sheep — Goats |
64/432 92/46 |
9 CFR 94 |
Yes 2 |
Certification to UHT for FMD affected regions. For non-FMD affected countries/regions a certificate of origin is required. |
US to review whether double pasteurisation acceptable. |
9 CFR 77, 78 |
92/46 95/343 |
Yes 2 |
TB and Brucella requirements for non-heat treated. |
EC to review US TB and brucella programmes. |
|
Public health |
||||||||||
|
— UHT-milk/sterilised Milk |
92/46 94/71 95/340 95/342 96/22 96/23 97/115 91/180 92/608 92/118 96/90 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110.3—110.93, 113, 131, 133, 135, 172, 184, 510—520, 556, 1210, 1240 40 CFR 180, 185 |
Yes 3 |
Existing trade conditions. |
US to review Import Milk Act. US to provide a detailed indication of how the EC request for equivalence for low-acid canned food can be considered. Joint assessment of laboratories to be completed. EC to provide appropriate information and documentation on procedures for audit and control of implementation by Member States. US to review information provided, and to carry out on-site verification of EC system. The outcome of the on-site verification to be discussed with EC. If on-site verification satisfactory, the equivalence determination to be finalised, and any necessary procedures carried out. |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110.3—110.93, 113, 131, 133, 135, 172, 184, 510—520, 556, 1210, 1240 40 CFR 180, 185 |
92/46 94/71 95/340 95/342 95/343 96/22 96/23 97/115 91/180 92/608 92/118 96/90 |
Yes 3 |
EC requirements for somatic cell and plate counts certification as per 95/343. |
US to consider including HACCP system in dairy products. Joint assessment of laboratories to be completed. Discussions on somatic cells and plate counts to continue. US to provide appropriate information and documentation on procedures for audit and control of implementation. EC to review information provided, and to carry out on-site verification of US system. The outcome of the on-site verification to be discussed with US. If on-site verification satisfactory, the equivalence determination to be finalised, and any necessary procedures carried out. |
|
Pasteurised milk Ordinance for grade A products and related documents. |
The US to provide a detailed indication of how the EC request for equivalence to ‘grade A’ can be considered, and thus to allow the possibility of export of such products to the US. |
Pasteurised milk Ordinance for grade A products and related documents. |
||||||||
|
— Pasteurised products |
92/46 94/71 95/340 95/342 96/22 96/23 97/115 91/180 92/608 92/118 96/90 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110.3—110.93, 113, 131, 133, 135, 172, 184, 510—520, 556, 1210, 1240 40 CFR 180, 185 |
Yes 3 |
Existing trade conditions. E coli requirement (for cheeses). |
US to review Import Milk Act. Discussions on differences in finished product criteria for E-coli to continue. Joint assessment of laboratories to be completed. EC to provide appropriate information and documentation on procedures for audit and control of implementation by Member States. US to review information provided, and to carry out on-site verification of EC system. The outcome of the on-site verification to be discussed with US. If on-site verification satisfactory, the equivalence determination to be finalised, and any necessary procedures carried out. |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110.3—110.93, 113, 131, 133, 135, 172, 184, 510—520, 556, 1210, 1240 40 CFR 180, 185 |
92/46 94/71 95/340 95/342 95/343 96/22 96/23 97/115 91/180 92/608 92/118 96/90 |
Yes 3 |
EC requirements for somatic cell and plate counts certification as per 95/343. US to consider including HACCP system in dairy products. |
Joint assessment of laboratories to be completed. Discussions on somatic cells and plate counts to continue. US to provide appropriate information and documentation on procedures for audit and control of implementation. EC to review information provided, and to carry out on-site verification of US system. The outcome of the on-site verification to be discussed with EC. If on-site verification satisfactory, the equivalence determination to be finalised, and any necessary procedures carried out. |
|
Pasteurised milk Ordinance for grade A products and related documents. |
The US to provide a detailed indication of how the EC request for equivalence to ‘grade A’ can be considered, and thus to allow the possibility of export of such products to the US. |
Pasteurised milk Ordinance for grade A products and related documents. |
||||||||
|
— Not pasteurised (raw or thermised) |
92/46 94/71 95/340 95/342 97/115 91/180 92/608 92/118 96/22 96/23 96/90 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110, 113, 133, 172, 184, 185, 510—520, 556, 1240 40 CFR 180 |
Yes 3 |
Compliance with E-coli requirement (for cheeses). |
Discussions on differences in finished product criteria for E-coli to continue. Joint assessment of laboratories to be completed. EC to provide appropriate information and documentation on procedures for audit and control of implementation by Member States. US to review information provided, and to carry out on-site verification of EC system. The outcome of the on-site verification to be discussed with EC. If on-site verification satisfactory, the equivalence determination to be finalised, and any necessary procedures carried out. |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110, 113, 133, 172, 184, 185, 510—520, 556, 1240 40 CFR 180 |
92/46 94/71 95/340 95/342 95/343 97/115 91/180 92/608 92/118 96/22 96/23 96/90 |
Yes 3 |
Compliance with EC requirements for somatic cell and plate counts certification as per 95/343. |
US to consider including HACCP system in dairy products. Joint assessment of laboratories to be completed. Discussions on somatic cells and plate counts to continue. US to provide appropriate information and documentation on procedures for audit and control of implementation. EC to review information provided, and to carry out on-site verification of US system. The outcome of the on-site verification to be discussed with US. If on-site verification satisfactory, the equivalence determination to be finalised, and any necessary procedures carried out. |
|
Prohibition on products not matured for more than 60 days at temperature above 35 °F (+2°C). |
The US to consider a dossier, to be submitted by the EC, for cheese not matured for more than 60 days, and thus to allow the possibility of export of such products to the US. |
|||||||||
|
14. Milk and milk-based products not for human consumption |
||||||||||
|
Animal health |
|
|
|
|
|
|
|
|
|
|
|
— Cattle including buffalo — Sheep — Goats All pasteurised or UHT or sterilised |
92/118 64/432 |
9 CFR 94.16 |
Yes 2 |
For non-FMD affected regions, a certificate of origin is required. For FMD affected regions, certification to UHT. |
US to review if double pasteurisation of products from FMD affected regions is acceptable. |
9 CFR 77, 78 |
92/118 95/341 |
NE |
|
|
|
— Unpasteurised colostrum for pharmaceutical use (10) |
92/118 |
9 CFR 94.16 |
NE |
|
|
9 CFR 77, 78 |
92/118 |
NE |
|
|
|
15. Minced meat |
||||||||||
|
Animal health |
||||||||||
|
— Ruminants |
64/432 72/461 72/462 |
9 CFR 94 |
Yes 2 |
Additional certification for bovines from BSE affected countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
72/462 |
NE |
|
|
|
— Pigs |
64/432 72/461 72/462 |
9 CFR 94 |
Yes 1 |
|
|
|
72/462 |
NE |
|
|
|
Public health |
||||||||||
|
Ruminants (8) Pigs |
94/65 |
9 CFR 301—381 |
Yes 3 |
Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnote (1) |
Equivalency shall be granted after the US has completed verification of veterinary delivery systems. This process shall be completed within 12 months of the date of entry into force of this Agreement. |
9 CFR 301—381 |
94/65 97/29 |
Yes 3 |
Derived from meat meeting the conditions of point six (fresh meat). Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnotes (2), (3) and (4). |
The EC shall evaluate the US residue programme, and additional information to be submitted by the US, to determine whether it meets the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement. The EC shall evaluate the US water standards to determine whether they meet the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement. Equivalency (Yes 2) shall be granted after the EC has completed verification of the application of the specified conditions. This process shall be completed within 12 months of the entry into force of this Agreement. EC to consider reviewing scope of definition of minced meat. |
|
16. Meat preparations |
||||||||||
|
Animal health |
||||||||||
|
— Ruminants — Equidae |
64/432 72/461 72/462 |
9 CFR 94 |
Yes 2 |
Additional certification for bovines from BSE affected countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
72/462 |
NE |
|
|
|
— Pigs |
64/432 72/461 72/462 |
9 CFR 94 |
Yes 1 |
|
|
|
72/462 |
NE |
|
|
|
— Poultry/Wild game/ Farmed game |
92/118 72/462 80/215 94/438 |
9 CFR 94 |
Yes 1 |
|
|
|
91/494 93/342 94/984 |
NE |
|
|
|
Public health |
||||||||||
|
Ruminants (8) Equidae Pigs Poultry |
94/65 |
9 CFR 301—381 |
Yes 2/3 |
Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnote (1). |
Equivalency shall be granted after the US has completed verification of veterinary delivery systems. This process shall be completed within 12 months of the date of entry into force of this Agreement. |
9 CFR 301—381 |
94/65 97/29 |
Yes 3 |
Derived from meat meeting the conditions of point 6 (fresh meat) and/or 7 (poultry meat). Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnotes (2), (3) and (4). |
The EC shall evaluate the US residue programme, and additional information to be submitted by the US, to determine whether it meets the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement. The EC shall evaluate the US water standards to determine whether they meet the EC level of protection. This evaluation shall be completed within six months of the entry into force of this Agreement. Equivalency shall be granted after the EC has completed verification of the application of the specified conditions. This process shall be completed within 12 months of the entry into force of this Agreement. |
|
Wild game (8) Farmed game (8) |
94/65 |
FIFRA, FFDCA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 113, 170—189, 510—529, 556 40 CFR 180, 185 |
NE |
Existing trade conditions |
|
FIFRA, FFDCA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 113, 170—189, 510—529, 556 40 CFR 180, 185 |
94/65 |
NE |
|
|
|
17. Animal casings for human consumption |
||||||||||
|
Animal health |
||||||||||
|
— Cattle |
92/118 64/432 72/461 72/462 |
9 CFR 96 |
Yes 2 |
Non-comminglement (see footnote (9)) No trade allowed for countries affected by BSE. |
US to review rules on BSE with respect to high/low incidence regions. US to review 94.8 (a) (i) (v) of CFR for non-comminglement. |
|
92/118 94/187 |
NE |
|
|
|
— Pigs |
92/118 64/432 72/461 72/462 |
9 CFR 96 |
Yes 2 |
Non-comminglement (see footnote (9)). Certification attesting to process and origin for casings originating in ASF free countries/regions but processed in ASF affected country/region. |
US to review 94.8 (a) (i) (v) of CFR for non-comminglement. |
|
92/118 94/187 |
NE |
|
|
|
— Sheep — Goats |
92/118 64/432 72/461 72/462 |
9 CFR 96 |
Yes 2 |
Non-comminglement (see footnote (9)). No trade allowed for countries affected by BSE. Certification attesting to process and country of origin for casings originating in BSE free countries but processed in BSE affected country. |
US to review 94.8 (a) (i) (v) of CFR for non-comminglement. |
|
92/118 94/187 |
NE |
|
|
|
Public health |
77/99 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 113, 114, 170—189, 510—529, 556 40 CFR 180, 185 |
NE |
|
|
FFDCA, FIFRA, PHSA 21 CFR 70—82, 101, 109, 110.3—110.93, 113, 114, 170—189, 510—529, 556 40 CFR 180, 185 |
77/99 92/118 Draft Decision notified to WTO. |
NE |
|
|
|
18. Animal casings not for human consumption |
||||||||||
|
Animal health |
||||||||||
|
— Cattle |
92/118 64/432 72/461 72/462 |
9 CFR 96 |
Yes 2 |
Non-comminglement (see footnote (9)). No trade allowed for countries affected by BSE. |
US to review rules on BSE with respect to high/low incidence regions. US to review 94.8 (a) (i) (v) of CFR for non-comminglement. |
|
92/118 94/187 |
NE |
|
|
|
— Pigs |
92/118 64/432 72/461 72/462 |
9 CFR 96 |
Yes 2 |
Non-comminglement (see footnote (9)). Certification attesting to process and origin for casings originating in ASF free countries/regions but processed in ASF affected country/region. |
US to review 94.8 (a) (i) (v) of CFR for non-comminglement. |
|
92/118 94/187 |
NE |
|
|
|
— Sheep — Goats |
92/118 64/432 72/461 72/462 |
9 CFR 96 |
Yes 2 |
Non-comminglement (see footnote (9)). No trade allowed for countries affected by BSE. Certification attesting to process and country of origin for casings originating in BSE free countries but processed in BSE affected country. |
US to review 94.8 (a) (i) (v) of CFR for non-comminglement. |
|
92/118 94/187 |
NE |
|
|
|
19. Hides and skins |
||||||||||
|
Animal health |
||||||||||
|
— Cattle — Sheep — Goats — Pigs |
92/118 72/461 72/462 |
9 CFR 95.5, 95.6 |
Yes 1 |
|
|
|
92/118 97/168 |
E |
|
EC to identify basis for salting requirement. |
|
20. Canned petfood containing high/low risk material |
||||||||||
|
— Containing mammalian material |
92/118 90/667 92/562 |
9 CFR 94, 95 FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
Yes 2 |
Special rules for BSE countries. Shelf stable for remainder. |
US to review rules on BSE with respect to high/low incidence regions. |
FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
92/118 94/309 96/449 97/199 |
E |
|
EC to examine US claim to be BSE free. EC to consider alternative guarantees for mammalian material, including US proposal to remove all risk material of known US TSE species from petfood. |
|
— Containing only non-mammalian material |
92/118 90/667 92/562 |
99 CFR 94, 95 FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
Yes 2 |
Shelf stable for remainder. |
|
FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
92/118 94/309 96/449 97/199 |
E |
Establishments shall have been validated by the US for alternative heat treatment including 30 day freedom from clostridia. |
|
|
21. Canned petfood containing only low risk material |
||||||||||
|
— Containing mammalian material |
92/118 90/667 |
9 CFR 94, 95 FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
Yes 2 |
Special rules for BSE countries. Shelf stable for remainder. |
US to review rules on BSE with respect to high/low incidence regions. |
FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
92/118 94/309 96/449 97/199 |
E |
|
|
|
— Containing only non-mammalian material |
92/118 90/667 |
9 CFR 94, 95 FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
Yes 2 |
Shelf stable. |
|
FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
92/118 94/309 96/449 97/199 |
E |
Establishments shall have been validated by the US for alternative heat treatment including 30 day freedom from clostridia. |
|
|
22. Dry and semi moist petfood containing only low risk material |
||||||||||
|
|
92/118 94/309 |
9 CFR 94, 95 FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
Yes 2 |
Restrictions for BSE countries. |
US to examine EC 90 °C core temperature requirement as providing sufficient guarantees against FMD, CSF, SVD, ASF and ND. US to review rules on BSE. |
FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
92/118 94/309 96/449 97/199 |
E |
Establishments shall have been validated by the US for alternative heat treatment including 30 day freedom from clostridia. |
|
|
23. Dry and semi moist petfood containing high/low risk material |
||||||||||
|
— Containing mammalian material |
92/118 94/309 |
9 CFR 94, 95 FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
Yes 2 |
Restrictions for BSE countries. |
US to examine EC 90 °C core temperature requirement as providing sufficient guarantees against FMD, CSF, SVD, ASF and ND. US to review rules on BSE with respect to high/low incidence regions. |
FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
92/118 94/344 96/449 97/199 |
E |
|
EC to examine US claim to be BSE free. EC to consider alternative guarantees for mammalian material, including US proposal to remove all risk material of known US TSE species from petfood. |
|
— Containing only non-mammalian material |
92/118 94/309 |
9 CFR 94, 95 FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
Yes 1 |
|
US to examine EC 90 °C core temperature requirement as providing sufficient guarantees against ND. |
FFDCA, FIFRA 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
92/118 94/344 97/199 |
E |
Establishments shall have been validated by the US for alternative heat treatment including 30 day freedom from clostridia. |
|
|
24. Bones and bone products for human consumption (‘other products’ as defined in Directive 77/99/EEC) |
||||||||||
|
Animal health |
||||||||||
|
Fresh meat (ruminants, horses, pigs) |
64/432 72/461 80/215 72/462 |
9 CFR 95 |
Yes 2 |
Restrictions for BSE countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
72/462 97/221 |
NE |
|
|
|
Farmed game — Pigs, deer |
91/495 |
9 CFR 95 |
Yes 2 |
Restrictions for BSE countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
91/495 |
NE |
|
|
|
Fresh meat — Poultry |
92/118 80/215 72/462 94/438 |
9 CFR 95 |
Yes 1 |
|
|
|
92/118 |
NE |
|
|
|
Feathered, farmed and wild game |
92/45 91/495 |
9 CFR 95 |
Yes 1 |
|
|
|
92/45 91/495 |
NE |
|
|
|
Wild game — Pigs, deer |
92/45 |
9 CFR 95 |
Yes 2 |
Restrictions for BSE countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
92/45 |
NE |
|
|
|
Public health |
||||||||||
|
All species (8) |
77/99 92/118 |
9 CFR 95 |
NE |
|
|
|
77/99 92/118 |
NE |
|
EC to consider establishing conditions. |
|
Feathered, farmed and wild game (8) |
64/433 77/99 92/118 |
FIFRA, FFDCA, 21 CFR 70—82, 108, 109, 110.3—110.93, 113, 170—189, 510—529, 556 |
NE |
|
|
FIFRA, FFDCA, 21 CFR 70—82, 108, 109, 110.3—110.93, 113, 170—189, 510—529, 556 |
77/99 92/118 Draft Decision notified to WTO. |
NE |
|
|
|
25. Bones, horns and hooves and their products not for human consumption |
||||||||||
|
Animal health |
96/239 |
9 CFR 95 |
Yes 1 |
|
|
9 CFR 53 |
94/446 |
NE |
|
|
|
26. Processed animal protein for human consumption |
||||||||||
|
Animal health |
||||||||||
|
Fresh meat (ruminants, equidae, pigs) |
64/432 72/461 80/215 72/462 |
9 CFR 95 |
Yes 2 |
Not accepted from BSE countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
72/462 97/221 |
NE |
|
EC to examine US claim to be BSE free. EC to consider alternative guarantees for mammalian material, including US proposal to remove all risk material of known US TSE species from petfood. |
|
Farmed game — Pigs, deer |
91/495 |
9 CFR 95 |
Yes 2 |
Not accepted from BSE countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
91/495 |
NE |
|
|
|
Fresh meat — Poultry |
92/118 80/215 72/462 94/438 |
9 CFR 95 |
Yes 1 |
|
|
|
92/118 |
NE |
|
|
|
Feathered, farmed and wild game |
92/45 91/495 |
9 CFR 95 |
Yes 1 |
|
|
|
92/45 91/495 |
NE |
|
|
|
Wild game — Pigs, deer |
92/45 |
9 CFR 95 |
Yes 2 |
Not accepted from BSE countries. |
US to review rules on BSE with respect to high/low incidence regions. |
|
92/45 |
NE |
|
|
|
Public health |
||||||||||
|
All species (8) |
77/99 92/118 |
|
Yes 1 |
|
|
|
77/99 92/118 |
NE |
|
|
|
Feathered, farmed and wild game (8) |
77/99 |
FIFRA, PHSA, FFDCA, 21 CFR 70—82, 108, 109, 110.3—110.93, 113, 170—189, 510—529, 556 |
NE |
|
|
FIFRA, PHSA, FFDCA, 21 CFR 70—82, 108, 109, 110.3—110.93, 113, 170—189, 510—529, 556 |
77/99 92/118 Draft Decisions notified to WTO. |
NE |
|
|
|
27. Processed animal protein not for human consumption |
||||||||||
|
Containing material of mammalian origin |
||||||||||
|
Ruminants |
92/118 90/667 |
9 CFR 95 FIFRA, FFDCA, 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
Yes 2 |
Not accepted from BSE countries. |
US to review rules on BSE with respect to high/low incidence regions. |
FIFRA, FFDCA, 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
90/667 92/118 92/562 94/344 96/449 97/198 |
NE |
|
EC to examine US claim to be BSE free. EC to consider alternative guarantees for mammalian material, including US proposal to remove all risk material of known US TSE species from petfood. |
|
Non-ruminants |
92/118 90/667 |
9 CFR 95 FIFRA, FFDCA, 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
Yes 3 |
|
|
FIFRA, FFDCA, 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
92/118 90/667 96/449 |
NE |
Establishments shall have been validated by the US for alternative heat treatment including 30 day freedom from clostridia. |
|
|
Containing only material of non-mammalian origin |
||||||||||
|
Poultry and fish |
92/118 90/667 |
9 CFR 95 |
Yes 1 |
|
|
|
90/667 92/118 92/562 94/344 97/198 |
NE |
Establishments shall have been validated by the US for alternative heat treatment including 30 day freedom from clostridia. |
|
|
Non-ruminants |
92/118 90/667 |
9 CFR 95 |
Yes 1 |
|
|
|
92/118 90/667 |
NE |
|
|
|
28. Serum of equidae |
||||||||||
|
Animal health |
92/118 94/143 |
9 CFR 95, 122 |
NE |
|
|
|
92/118 94/143 |
NE |
|
|
|
29. Blood and blood products intended for human consumption |
||||||||||
|
Animal health |
||||||||||
|
Fresh meat (ruminants, equidae, pigs) |
64/432 72/461 80/215 72/462 |
9 CFR 95, 122 |
E |
BSE rules for ruminants. |
US to review rules on BSE with respect to high/low incidence regions. US to produce generic conditions for EC. |
9 CFR 53 |
72/462 97/221 |
NE |
|
|
|
Farmed game — Pigs, deer |
91/495 |
9 CFR 95, 122 |
Yes 2 |
BSE rules for ruminants. |
US to review rules on BSE with respect to high/low incidence regions. |
|
91/495 |
NE |
|
|
|
Fresh meat — Poultry |
92/118 80/215 72/462 94/438 |
9 CFR 95, 122 |
Yes 1 |
|
|
|
92/118 |
NE |
|
|
|
Feathered, farmed and wild game |
92/45 91/495 |
9 CFR 95, 122 |
Yes 1 |
|
|
|
92/45 91/495 |
NE |
|
|
|
Wild game — Pigs, deer |
92/45 |
9 CFR 95, 122 |
Yes 1 |
|
|
|
92/45 |
NE |
|
|
|
Public health |
77/99 |
9 CFR 301—381, 416, 417 FFDCA, FIFRA, 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
NE |
|
|
9 CFR 301—381, 416, 417 FFDCA, FIFRA, 21 CFR 110.3—110.93, 507—509, 570, 573—589 |
77/99 92/118 Draft Decision notified to WTO. |
NE |
|
EC to consider establishing conditions. |
|
30. Blood and blood products not intended for human consumption |
||||||||||
|
Animal health |
92/183 92/118 |
9 CFR 95.4, 122 |
Yes 2 |
BSE rules for ruminants. Permit required. |
US to review rules on BSE with respect to high/low incidence regions. |
9 CFR 53 |
92/183 92/118 |
Yes 2 |
Bluetongue treatment requirements. |
EC to consider use of tests for bluetongue in place of treatment. |
|
31. Lard and rendered fats intended for human consumption |
||||||||||
|
Animal health |
||||||||||
|
Fresh meat (ruminants, horses, pigs) |
64/432 72/461 80/215 |
9 CFR 95 |
Yes 2 |
BSE rules for ruminants. |
US to review rules on BSE with respect to high/low incidence regions. |
|
72/462 97/221 |
NE |
|
|
|
Farmed game — Pigs, deer |
91/495 |
9 CFR 95 |
Yes 2 |
BSE rules for ruminants. |
US to review rules on BSE with respect to high/low incidence regions. |
|
91/495 |
NE |
|
|
|
Fresh meat — Poultry |
92/118 80/215 94/438 |
9 CFR 95 |
Yes 1 |
|
|
|
92/118 |
NE |
|
|
|
Feathered, farmed and wild game |
92/45 91/495 |
9 CFR 95 |
Yes 1 |
|
|
|
92/45 91/495 |
NE |
|
|
|
Wild game — Pigs, deer |
92/45 |
9 CFR 95 |
Yes 2 |
BSE rules for ruminants. |
US to review rules on BSE with respect to high/low incidence regions. |
|
92/45 |
NE |
|
|
|
Public health |
||||||||||
|
All species (8) |
77/99 92/118 |
|
NE |
|
|
|
77/99 92/118 |
NE |
|
|
|
Feathered, farmed and wild game (8) |
77/99 |
9 CFR 301—381, 416, 417 FIFRA, PHSA, FFDCA, 21 CFR 70—82, 108, 109, 110.3—110.93, 113, 170—189, 510—529, 556 |
NE |
|
|
9 CFR 301—381, 416, 417 FIFRA, PHSA, FFDCA, 21 CFR 70—82, 108, 109, 110.3—110.93, 113, 170—189, 510—529, 556 |
77/99 92/118 Draft Decision notified to WTO. |
NE |
|
|
|
32. Lard and rendered fats not intended for human consumption |
||||||||||
|
|
92/118 90/667 72/461 |
9 CFR 95 |
Yes 2 |
BSE rules for ruminants. |
US to review rules on BSE with respect to high/low incidence regions. |
|
92/118 Draft Decision notified to WTO. |
NE |
|
EC to review requirements to consider inclusion of alternative heat treatment systems. EC to review US bacteriological testing regime for protein fraction. |
|
33. Raw material for feeding stuffs, pharmaceutical or technical use |
||||||||||
|
Animal health |
92/118 |
9 CFR 95, 122 |
Yes 1 |
|
|
9 CFR 53 |
92/118 |
E |
|
EC to consider laying down certification requirements for imports. |
|
34. Apiculture products for apiculture |
||||||||||
|
Animal health |
92/118 |
|
E |
|
|
|
92/118 94/860 |
NE |
|
|
|
35. Game trophies |
||||||||||
|
Animal health |
92/118 |
9 CFR 95 |
Yes 1 |
|
|
9 CFR 53 |
92/118 96/590 |
E |
|
|
|
36. Manure |
||||||||||
|
Animal health |
92/118 |
9 CFR 95 |
E |
|
US to provide temperature requirements for manure from regions affected by serious transmissible disease. |
9 CFR 53 |
92/118 |
E |
|
|
|
37. Wool, feathers and hair |
||||||||||
|
Animal health |
||||||||||
|
— Wool |
92/118 |
9 CFR 95 |
Yes 1 |
|
|
9 CFR 53 |
92/118 |
NE |
|
|
|
— Pig bristles |
92/118 |
9 CFR 95 |
Yes 1 |
|
|
9 CFR 53 |
92/118 94/435 |
NE |
|
|
|
Public health |
|
FFDCA, PHSA 21 CFR 1240.70 |
NE |
|
|
FFDCA, PHSA 21 CFR 1240.70 |
|
NE |
|
|
|
38. Honey |
||||||||||
|
Animal health |
|
|
NE |
|
|
|
|
NE |
|
|
|
Public health |
92/118 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 109, 110.3—110.93, 520.182, 520.1660d |
NE |
|
|
FFDCA, FIFRA, PHSA 21 CFR 70—82, 109, 110.3—110.93, 520.182, 520.1660d |
92/118 |
NE |
|
|
|
39. Frogs' legs |
||||||||||
|
Animal health |
|
|
|
|
|
|
|
|
|
|
|
Public health |
92/118 96/340 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110.3—110.93, 113, 114, 123, 1240 |
NE |
|
|
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110.3—110.93, 113, 114, 123, 1240 |
92/118 96/340 |
NE |
|
EC to review US HACCP rules when submitted. |
|
40. Snails for human consumption |
||||||||||
|
Animal health |
|
|
|
|
|
|
|
|
|
|
|
Public health |
92/118 96/340 |
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110.3—110.93, 113, 114, 123, 1240 |
NE |
|
|
FFDCA, FIFRA, PHSA 21 CFR 70—82, 108, 110.3—110.93, 113, 114, 123, 1240 |
92/118 96/340 |
NE |
|
|
|
41. Egg products for human consumption |
||||||||||
|
Animal health |
90/539 |
9 CFR 94 |
Yes 2 |
Permit required from areas affected by Newcastle disease. |
US to review permit requirement. |
|
90/539 93/342 |
Yes 1 |
|
|
|
Public health |
89/437 91/684 92/118 96/23 |
7 CFR 59 EPIA Public Law 91-597 |
E |
|
US to supply information on the legal basis for recognition of equivalence. US to complete assessment of EC public health legislation. |
7 CFR 59 EPIA Public Law 91-597 |
89/437 91/684 92/118 96/23 97/38 |
E |
Establishments listed in accordance with footnote (7), and fulfilling the relevant provisions of footnote (2). The following tests are to be conducted, as specified in Annex VI to Directive 89/437, on US egg products for dispatch to Europe: Chemical tests — 3 OH butyric acid — lactic acid — succinic acid — egg shell remains, egg membrane, other particles. Bacteriological tests — mesophile counts — enterobacteriaceae — salmonella — staphylococcus Methods Internationally recognised methods such as: ISO, NMKL, AOAC. |
EC to complete assessment of US public health legislation. |
|
42. Shell eggs |
||||||||||
|
Animal health |
90/539 |
9 CFR 94 |
Yes 2 |
Permit required from areas affected by Newcastle disease. |
US to review permit requirement. |
9 CFR 94 |
90/539 93/342 |
Yes 1 |
|
|
|
Public health |
89/437 91/684 94/371 96/23 |
FFDCA, FIFRA, PHSA, EPIA 21 CFR 5.10(a)(4) and (a)(13), 70—82, 100.135, 110.3—110.93, 172.140, 172.882, 182.884, 178, 520, 524, 556, 558, 1240 40 CFR 180 7 CFR 56 |
E |
|
US to review legal basis for recognition of equivalence. US to complete assessment of EC public health legislation. |
FFDCA, FIFRA, PHSA, EPIA 21 CFR 5.10(a)(4) and (a)(13), 70—82, 100.135, 110.3—110.93, 172.140, 172.882, 182.884, 178, 520, 524, 556, 558, 1240 40 CFR 180 7 CFR 56 |
89/437 91/684 94/371 96/23 |
E |
Footnote (4). |
EC to complete assessment of US public health legislation. |
|
43. Gelatin for human consumption |
||||||||||
|
Animal health |
92/118 |
9 CFR 93, 94, 95, 309, 310, 311 |
NE |
|
|
9 CFR 93, 94, 95, 309, 310, 311 |
92/118 |
Yes (2) |
(SANCO/10451/2003 Rev. 1 Draft Commission Decision on health certificates for the importation of animal products from the United States) |
|
|
Public health |
92/118 |
FFDCA, FIFRA, PHSA 21 CFR 70-82, 109, 110.3-110.110, 570, 573-589 |
NE |
|
|
FFDCA, FIFRA, PHSA 21 CFR 70-82, 109, 110.3-110.110, 570, 573-589 |
92/118 |
Yes (2) |
(SANCO/10451/2003 Rev. 1 Draft Commission Decision on health certificates for the importation of animal products from the United States) |
|
|
44. Gelatin for technical use |
||||||||||
|
Animal health |
1774/2002 |
9 CFR 94 |
NE |
|
|
9 CFR 94 |
1774/2002 |
NE |
|
|
|
Public health |
1774/2002 |
FFDCA, FIFRA, PHSA 21 CFR 70-82, 109, 110.3-110.93, 570, 573-589 |
NE |
|
|
FFDCA, FIFRA, PHSA 21 CFR 70-82, 109, 110.3-110.93, 570, 573-589 |
1774/2002 |
NE |
|
|
|
45. Collagen for human consumption |
||||||||||
|
Animal health |
92/118 |
9 CFR 94 |
NE |
|
|
9 CFR 93, 94, 95, 309, 310, 311 |
92/118 |
Yes (2) |
(SANCO/10451/2003 Rev. 1 Draft Commission Decision on health certificates for the importation of animal products from the United States) |
|
|
Public health |
92/118 |
FFDCA, FIFRA, PHSA 21 CFR 70-82, 109, 110.3-110.93, 570, 573-589 |
NE |
|
|
FFDCA, FIFRA, PHSA 21 CFR 70-82, 109, 110.3-110.93, 570, 573-589 |
92/118 |
Yes (2) |
(SANCO/10451/2003 Rev. 1 Draft Commission Decision on health certificates for the importation of animal products from the United States). |
|
FOOTNOTE 1
The pathogen reduction: hazard analysis and critical control point (HACCP) systems; final rule was published at 61 Federal Register 38806—38989 and amends various provisions of CFR parts 304, 310, 320, 327, 381, 416 and 417.
Provisions on SSOPs applicable.
The USA and the EC shall discuss, well in advance of their date of implementation, the staged elements in the above rule to determine whether any further special conditions are needed.
FOOTNOTE 2
Horizontal issues, fresh meat, meat products, game meat, poultry meat, minced meat, meat preparations, egg products
(a) Packaging material
Packaging material shall be kept in separate rooms that are used exclusively for this purpose and free of dust and vermin.
Packaging material shall not be stored on the floor.
Waxed assembled boxes shall not be nested, unless a liner is added.
Assembled boxes with liners shall not be nested.
Boxes shall not be handled by personnel who are handling exposed product.
Boxes shall be assembled in a sanitary manner, either in a separate room or, if on the cutting room floor, never within 3 metres of exposed product.
(b) Facility requirements for light coloured walls and cove molding
Walls shall be smooth, durable, impermeable, and of a colour which permits detection of insanitary conditions.
Walls shall have washable surfaces.
Walls and floor junctures shall be constructed and maintained so as to assure that surfaces are clean and free of contamination. Establishments that do not use cove molding to provide a smooth transition from floor to wall to facilitate cleaning must provide an equivalent alternative means, such as sealing of cracks between walls and floors, to maintain sanitary conditions.
(c) Medical certification by a medical doctor
Prior to employment, new employees shall be examined by a medical doctor or by another medically qualified person who is sufficiently trained to identify communicable diseases and working under the supervision of a medical doctor.
Establishments shall have in place an appropriate programme to continuously monitor employee health.
Pre-employment examinations and ongoing health monitoring shall be carried out either by a medical doctor or by a person with appropriate medical training (e.g. a physician's assistant or a registered nurse).
All cases of suspected disease shall be referred to a medical doctor for diagnosis.
Establishments shall keep records of medical examinations and shall make those records available to auditors upon request.
(d) Wooden pallets in exposed product areas
The use of wooden pallets in areas where there is exposed product shall be phased out. In the interim:
Those establishments which are already using plastic pallets shall continue to do so.
When wooden pallets are used in coolers or freezers, all product present shall be hygienically packaged to prevent contact of product with wood.
(e) Separation of lavatories and work areas
Toilet rooms shall be properly ventilated and shall be separated from exposed product rooms by either a vestibule or a dressing room.
(f) Dry storage of non-food material
Detergents, disinfectants and similar substances shall be stored separately from food and from wrapping and packaging material.
(g) Water testing
Water testing shall continue to be carried out in accordance with EC requirements.
FOOTNOTE 3
Fresh meat, game meat, meat products, minced meat and meat preparations of red meat species and poultry.
(a) Waste water
All establishments shall have an efficient drainage and plumbing system, and all drains and gutters shall be properly installed with traps and vents approved by FSIS, in accordance with 9 CFR 381.49 (a), (c).
(b) Separate storage of edible and inedible products
Condemned and other inedible meat and offal shall be removed in a hygienic manner, and as quickly as possible, from rooms containing edible material.
(c) Separate storage of packaged and unpackaged products
Unpackaged meat may not be stored in chilling or freezer rooms containing packaged meat.
(d) Structural wood
Wooden structures shall be in good condition, impermeable, smooth, durable rot-proof and sealed with a waterproof coating.
(e) Use of suspended showers, sprays and hoses
Meat shall not be contaminated by splashing.
They shall not be used as a substitute for handwashing facilities.
(f) Sterilisation of equipment
Establishments shall provide sterilisation equipment (batch or local sterilisers) to clean utensils as often as necessary. Implements such as knives or hooks which come into contact with meat shall be cleaned and sterilised frequently, and in any case whenever they have been in contact with contaminated material or surfaces such as the external surfaces of hides. Sterilisation shall be done with hot (> 82 °C) water.
FOOTNOTE 4
Additional guarantees for Finland and Sweden
For trade from the USA to Sweden and Finland, the USA will certify in accordance with Council Decision 95/409/EC (fresh: veal, beef and pigmeat), Council Decision 95/410/EC (live poultry for slaughter), Council Decision 95/411/EC (fresh poultrymeat), Commission Decision 95/160/EC (breeding poultry and day old chicks), Commission Decision 95/161/EC (laying hens) and Commission Decision 95/168/EC (table eggs for human consumption).
No attestation is required for fresh meat as defined in Council Directive 72/462/EEC intended for an establishment for the purposes of pasteurisation, sterilisation or for treatment having an equivalent effect.
FOOTNOTE 5
Fresh meat, game meat, meat products, minced meat, meat preparations
(a) Accommodation for sick and suspect animals
Wood shall not be used for pens for sick and suspect animals.
Sick and suspect animals shall not be allowed to come into contact with animals intended for slaughter for export to the Community.
Pens for sick and suspect animals shall be sited and constructed to preclude contact with animals intended for slaughter for export to the Community and effluent from such pens shall not flow into adjoining pens or passageways.
(b) Veterinary supervision of ante-mortem inspection
All cattle intended for slaughter for export to the EC shall be inspected by an official FSIS veterinarian, except:
which shall be inspected by an official FSIS inspector with appropriate training, knowledge, skills and abilities to carry out this function.
All pigs intended for slaughter for export to the EC shall be inspected by an official FSIS veterinarian, except for market hogs (animals up to one year of age), which shall be inspected by an official FSIS inspector with appropriate training, knowledge, skills and abilities to carry out this function.
All animals demonstrating abnormal signs shall be diagnosed and disposed of by an official FSIS veterinarian.
(c) Trichina testing
Establishments shall test horsemeat for trichinae.
Pigmeat shall be tested or subjected to cold treatment in accordance with 9 CFR 318.10.
(d) Opening of stomachs and intestines
There must be a separate room for emptying and cleaning stomachs and intestines, unless the processing is done by closed-circuit mechanical equipment which avoids contamination and eliminates odours.
(e) Pig hearts incision
For market hogs (animals up to one year old) which are destined or from which some part is destined for the EC a statistically representative sample, both in numbers or percentage and geographical origin, of hearts shall be incised and their interior surfaces inspected by FSIS personnel, with the results being recorded.
The USA shall inform the EC of the sampling methodology, level of confidence, and programme they intend to use for the sampling referred to above.
Hearts of all sows and boars (animals over one year of age) which are destined or from which some part is destined for the EC shall be incised and their interior surfaces inspected by FSIS personnel, with the results being recorded.
(f) Batch condemnation
If carcases, offal and blood are not correlated at the final post-mortem inspection point, a batch system shall be operated in such a way that FSIS can demonstrate that if a carcase is condemned its offal and blood shall also be condemned.
(g) Partial approval
The veterinary authorities of the EC and the USA may on a bilateral basis grant request for partial approval of red-meat establishments for certain products, in accordance with the general and specific provisions of this Agreement in respect of hygienic production and ante and post-mortem inspection of slaughter animals, under the following conditions:
the establishment shall develop a quality assurance (QA) programme which addresses the mode of operation, the identification of product, and the segregation of the product from receiving to shipping. Establishments which want to apply for partial approval must meet the facility requirements to ensure physical and/or time separation of approved and non-approved products;
the QA shall include an establishment monitoring schedule and a log to document both monitoring actions and corrective actions;
the QA programme shall be acceptable to the regulatory inspector in charge of the establishment and the controlling veterinary authority of the importing party on request;
the regulatory inspector in charge of the establishment shall monitor the establishment's application of the QA programme and document such monitoring and ensure correction of deficiencies;
the importing Party may verify the practical implementation of the QA programme. In this case, the establishment needs to be in a position to demonstrate the programme on the spot during an inspection. For this purpose, all relevant documentation shall be presented;
should an inspection on the spot and/or the document-check in an establishment reveal serious deficiencies, the possibility of partial approval may either be refused or revoked.
FOOTNOTE 6
Poultrymeat
(a) Counterflow chilling
Where counterflow chilling systems are used, alternative chilling systems to the EC standards may be used providing equivalent guarantees as regards avoidance of cross contamination, and carcase temperatures at the point of exit from the chilling systems as set out under point (b), which have been validated and assessed by FSIS before the establishment is proposed for listing for export to the EC. This validation and assessment shall be carried out without the use of antimicrobial treatment (decontamination), throughout a full day's production, and with microbiological analyses for aerobic plate counts, enterobacteriacae and E-coli before and after chilling. This assessment shall be carried out each time any changes are made to a plant's chilling system. Records shall be kept of the validations and assessments, and FSIS shall make these available to the EC.
(b) Poultry product temperature requirements
Poultry shall be chilled to an internal temperature of 40 °F (4,4 °C) in the shortest time possible after slaughter.
When further processing (cutting) occurs after poultry has been chilled to 40 °F, the internal temperature may exceed 40 °F for a maximum of one hour, but may not exceed 50 °F (10 °C).
(Transportation temperature shall be in accordance with 9 CFR 381.66.)
(c) Crushed ice
The use of crushed ice must not result in cross contamination of the product. When crushed ice is used for further transport or storage, stacking of boxes with leakholes or other practices which could result in cross contamination shall be prohibited.
FOOTNOTE 7
Establishment listing (applicable to all products where listing provisions apply)
|
1. |
The exporting Party is responsible for ensuring that establishments/plants authorised to export, and products certified for export, meet the relevant requirements. The exporting Party shall screen establishments to ensure that they meet the relevant requirements before proposing establishments for listing for export. The list, or lists, of approved establishments, and additions and deletions to such lists, shall be supplied to the importing Party by the exporting Party. The importing Party shall make modifications to the lists of approved establishments efficiently, on the basis of the information supplied by the exporting Party. Dissemination of such lists shall be carried out without delay ( *1 ). |
|
2. |
The importing Party may carry out verification procedures, including inspection of the establishments, to ensure that the relevant requirements are being met. |
|
3. |
The Parties will work towards increasing the responsibility for the management of lists of establishments by the exporting Party in the light of experience obtained under the operation of the provisions of paragraphs 1 and 2. |
|
4. |
The Parties will review the functioning of the abovementioned provisions regarding lists of establishments in the light of experience at each meeting of the Committee provided for under Article 14, and for the first time no later than 31 December 1997. |
FOOTNOTE 8
Bison and Water Buffalo
For exports to the USA, bison and water buffalo are considered as game meat.
For exports to the EC, bison and water buffalo are considered as fresh meat.
FOOTNOTE 9
Non-comminglement — meat, meat products, game meat, poultry meat, minced meat, meat preparations
Establishments which slaughter both animals whose meat is eligible for export and animals whose meat is not eligible for export to one of the Parties, or handle such meat, shall comply with the following conditions.
Animals from which the meat is intended for export shall be kept separate from those which are not of the same status while at the slaughter establishment.
Following slaughter of animals which are not eligible for export and before slaughter of animals eligible for export purposes, all areas, utensils and equipment liable to contact the live animals and meat, including stunning, bleeding, flaying, deboning, cutting and packing areas shall be cleaned and disinfected. Staff shall change into clean protective clothing and wash their hands and boots thoroughly.
Meat intended for export shall not be handled, cut or otherwise processed in the same room at the same time as meat not eligible for export.
Meat intended for export shall be packed in clean new packaging which is clearly distinguishable from that containing meat not eligible for export. It shall be stored in such a way as to ensure that no cross contamination occurs.
Records of the origin of the animals from which the meat is produced shall be retained for a period of six months after export. They shall be available for inspection by the Regulatory Authority.
Compliance with the above conditions shall be certified by an official veterinarian.
FOOTNOTE 10
Milk and milk products not for human consumption
Excludes products regulated as animal drugs in the USA.
FOOTNOTE 11
Residue testing
Residue testing shall continue to be carried out by the USA in accordance with applicable EC requirements.
ANNEX VI
GUIDELINES FOR CONDUCTING AN AUDIT
Where standards, guidelines, or recommendations pertaining to the conduct of audits are adopted by one of the relevant international standard-setting organisations, the Parties will review the contents of this Annex, and make any appropriate modifications.
General Provisions
1. Definitions
The following definitions shall apply to terms used in this Annex:
audit — assessment of performance;
auditee — the exporting Party whose enforcement and control programme is the subject of the audit;
auditor — the importing Party that conducts the audit;
establishment — processing plant for animals or animal products;
facility — site other than processing plants where animals or animal products might be handled, excluding retail premises;
animal health investigation — a site visit undertaken to gather or verify information related to the status or conditions of a particular region with regard to one or more of the animal diseases identified in Annex III.
2. General principles
|
2.1. |
The auditor and the auditee should cooperate in carrying out audits in accordance with the provisions set out in this Annex. The audit team should include representatives of both the auditor and the auditee, and the auditee should designate personnel responsible for facilitating the audit. Specialised professional skills may be necessary to carry out audits of specialised systems and programmes. Information is collected through interviews, review of documents and records, and site visits. Changes to controls since the adoption of the Agreement or since the previous audit are included. Information may be verified through inquiries and checks on other sources; these may include physical observation, measurements, samples and records. Information obtained during the course of the audit should be documented. |
|
2.2. |
Audits should be designed to check the effectiveness of the auditee's enforcement and control programme rather than to reject individual animals, consignments of food or establishments. The auditee's enforcement and control programme covered by the Agreement should be adequately assessed.
|
|
2.3. |
The auditee must operate a documented programme to demonstrate to the auditor that standards are being met on a consistent basis. |
|
2.4. |
The frequency of audits should be based on the performance of the exporting Party in carrying out its enforcement and control programme. A low level of performance should result in an increased frequency of audit, for example to ensure that unsatisfactory performance has been corrected.
|
|
2.5. |
Audits, and the decisions based on them, should be made in a transparent and consistent manner. The auditor should:
2.5.1.
Ensure that audit conclusions are based on objective evidence or data and observations, which can be verified as accurate and reliable;
2.5.2.
Remain free of any conflicting interest or improper influence;
2.5.3.
Ensure that the audit procedure is conducted with the objectives of
—
verifying that previously recognised conditions of equivalence are being delivered by the exporting party, and
—
identifying to the auditee areas where improvements can be introduced to enhance the performance of the auditee's documented control programme so that it can deliver initially, or continue to deliver, a condition of equivalence necessary to meet the importing party's appropriate level of protection;
2.5.4.
Ensure that all documents and records received during the audit are retained and safeguarded as agreed by both parties and according to each party's applicable laws and regulations;
2.5.5.
Ensure that commercial confidentiality is respected according to each party’s applicable laws and regulations. The auditee should:
2.5.6.
Provide information within the scope of the audit, which is requested by the auditor, in a timely manner during the audit or within 20 working days thereafter to ensure that the audit objectives can be met;
2.5.7.
Cooperate with and assist the auditor in the performance of his/her duties so that the audit objectives are achieved. This includes:
—
informing personnel involved in the audit about its objectives;
—
appointing suitably qualified members of staff to accompany the audit team,
—
providing the necessary facilities needed for the audit team in order to ensure an effective and efficient audit process,
—
providing access to the sites and to documents necessary to carry out the audit, as requested by the auditor.
|
|
2.6. |
Animal health investigations Animal health investigations are conducted in order to gather appropriate epidemiological and other information concerning the disease status of a particular region (whether a Member State/State, part of a Member State/State or parts of more than one Member State/State). An animal health investigation may be carried out by one party (referred to here as the importing party) to support the initial determination made by the other party (referred to here as the exporting party) of the disease status of a region (i.e. first-time recognition of freedom from a specified disease), or following a disease outbreak. |
OPERATIONAL GUIDELINES
Preparing for audits
3. Advance preparation
3.1. Programming of audits
In order to ensure that audits can be adequately prepared and carried out in the most efficient manner, the Parties should:
3.2. Audit initiation
The following will normally provide a basis for the initiation of audits:
In all cases, the auditor should provide the auditee with sufficient notice of the intended audit, in order to enable it to make the arrangements necessary for a satisfactory completion of the audit. The advance time of this notice should reflect the urgency related to public and animal health associated with its performance.
Communication by the auditor to the auditee
3.3. Pre-audit activities
3.3.1. Preparation of the audit plan
In consultation with the auditee, the auditor should prepare an audit plan. The audit plan should be submitted by the auditor to the auditee sufficiently in advance of the audit to allow time for information to be supplied by the auditee, preferably 60 days prior to the intended commencement date of the audit. The audit should be designed to be flexible in order to permit changes in emphasis based on information gathered prior to, or during the audit.
The plan should include:
3.3.2. Agreement with the auditee of the plan and dates
If the auditee objects to any provisions detailed in the audit plan, such objections are to be made known immediately to the auditor, usually within 10 working days after receipt of the audit plan. Objections should be resolved between the auditor and the auditee. Proposed amendment(s) to the audit plan, as a consequence of information obtained either prior to or during the audit, should be communicated by the proposing party to the other party as soon as practicable.
3.3.3. Obtaining the necessary documentation from the auditee
Prior to the audit, the auditor may request documentation from the auditee that is relevant to its preparation and execution. Such documentation may include, for example:
The auditor may request clarification from the auditee concerning any documentation that has been submitted.
Conducting the audit
4. Opening meeting
The auditee and auditor should have an opening meeting at a site agreed to in advance by both sides. Where necessary and appropriate to clarify issues pertaining to the audit, the opening meeting may be held in Washington, D.C. for audits conducted by European Commission teams, or in either Brussels, Belgium or Grange, Ireland for audits conducted by US teams. In other cases, opening meetings may be held at appropriate sites, such as EU Member State capitals or US cities, as may be practical and convenient for the particular audit. Wherever the opening meeting takes place, it should be chaired by an appropriate representative of the auditee's competent authority(ies). The purpose of an opening meeting is to:
5. Document review
|
5.1. |
The document review may include, for example, the following:
—
records concerning compliance programmes,
—
inspection and internal audit reports,
—
documentation concerning corrective actions and sanctions,
—
records of compliance actions taken,
—
sampling plans and their results,
—
documents associated with verification,
—
regulatory procedures followed by the auditee.
|
|
5.2. |
In the case of an audit that is subsequent to a determination of equivalence, the document review may also consist of a review of relevant changes to the inspection and certification systems since the determination of equivalence or since the previous audit. |
|
5.3. |
The auditee will cooperate fully with the auditor in the document review process and help to ensure that the auditor has access to requested documents and records. |
6. On-site verification
|
6.1. |
The decision by the auditor as to the nature and extent of on-site verifications should take into account factors such as the area concerned, the history of conformity with requirements by the sector or exporting country as determined by prior audits and/or veterinary checks at the border (including results of sampling and analysis of import consignments), the volume of product produced and imported or exported, changes to the infrastructure and the nature and operation of the national inspection and certification systems. |
|
6.2. |
On-site verification may involve visits to production and manufacturing establishments, facilities, food handling or storage areas and control laboratories to check the accuracy of the information contained in the documentary material referred to in 5.1. |
|
6.3. |
When checks of establishments or facilities are carried out, the auditee will carry out the check of the establishment or facility, following the auditee’s usual procedures, and the auditor will generally participate as an observer, though the auditor is free to check other aspects of performance, if deemed necessary. Due to time constraints, the auditor may elect not to observe a full, comprehensive inspection by the auditee, but may, instead, verify particular inspection practices through off-site interviews with the auditee’s inspection staff. |
|
6.4. |
The auditee will cooperate fully with the auditor in the on-site verification process and facilitate the auditor's entry into the establishments and facilities that are the subject of the on-site verification. |
|
6.5. |
Where on-the-spot checks reveal a serious potential or actual risk to human or animal health, the auditor should immediately inform the auditee of such an assessment, who should take appropriate action to correct an identified and confirmed risk. |
7. Follow-up audit
A follow-up audit may be conducted to verify the correction of deficiencies identified in a prior audit.
8. Working documents
Working documents may include checklists of elements to evaluate, such as the following:
8.1. Support documents
Documents supporting audit findings, conclusions and recommendations should be standardised as much as possible in order to make the performance of the audit and the presentation of its findings uniform, transparent and reliable. The support documents may include any aides memoire or other background information of elements to evaluate.
9. Closing meeting
As with the opening meeting, the closing meeting may be held at a site that is mutually convenient to both the auditee and the auditor. The closing meeting should also be chaired by an appropriate representative of the auditee's competent authority(ies).
The purpose of the closing meeting is to:
Post-audit activities
10. Audit report
The audit report should provide a balanced picture of the audit findings, and include conclusions and recommendations that accurately reflect these findings. It should normally cover the following:
|
10.1. |
Commercial confidentiality must be respected in the preparation and subsequent distribution of the audit report. Prior to the audit, each party will inform the other of its laws and procedures for protecting confidential commercial information and other information that may be deemed sensitive by one or both parties. Each party will respect fully its own requirements for protecting confidential information. Where significant differences exist between the parties in the nature of information that must be protected, the parties will identify these differences prior to the audit and agree on the appropriate procedures to be followed. |
|
10.2. |
Draft reports are to be sent to the auditee within the time limits specified in the Agreement. The auditee may comment within 60 days, and should describe any specific corrective actions that will be or have been taken in order to deliver equivalence initially, or to continue to deliver equivalence, including target dates for completion. |
|
10.3. |
Amendments to the text of the final report in response to comments from the competent authority should be limited to the correction of factual inaccuracies. However, other comments made by the auditee may be indicated separately in the report if they serve to clarify the report’s contents. The auditee’s comments should, in any case, be attached to the final report. |
11. Corrective action follow up
Verification of corrective action necessary to deliver equivalence will vary according to the nature of the original deficiency. Verification of corrective action by the auditee may include the following:
The follow up audit process is similar to the normal audit, but it would focus on confirming that the action taken by the auditee satisfactorily addresses and resolves the identified deficiencies. A follow up report concerning the corrective action should be prepared and distributed in a manner similar to the original audit report.
Animal health investigations
12. Animal health investigations
12.1. General principles
All parties involved in an animal health investigation should cooperate in carrying out the investigation in an open and transparent manner, with a view to completing all necessary procedures as quickly as possible.
12.2. Procedures
12.2.1. Programming of animal health investigation and animal health investigation initiation
In most cases, this investigation will be undertaken at the request of the exporting party. The results of an animal health investigation should provide essential information regarding disease risk associated with exports of specified commodities from that region. The importing party shall acknowledge such a request in a timely manner, and shall identify a contact person to work closely with representatives of the exporting party. Necessary site visits will be scheduled expeditiously with the input of all parties.
In the event of an outbreak of one of the diseases identified in Annex III and in case that safeguard or regionalisation measures have been adopted, the importing party may require that an animal health investigation take place before trade in affected products can be resumed. In order to minimise the disruption of trade and facilitate the recognition of disease freedom or identification or appropriate risk mitigation measures, the appropriate representatives of both the importing and exporting parties will work to schedule the investigation as quickly as possible. While the timing of the visit will depend on progress in bringing the outbreak under control, the two parties should enter into discussions at the earliest practical stage.
12.2.2. Pre-visit activities
The importing party will identify the regions to be visited as part of the site visit, as well as the types of entities to be included, in direct communication with the exporting party. The two parties should work in close consultation to prepare an investigation plan that covers the following points:
The investigation plan should be completed prior to the departure of the investigation team and transmitted to all parties involved in the animal health investigation.
12.2.3. Conducting the investigation
12.2.3.1. Opening meeting
An opening meeting should be held between representatives of all parties. At this meeting, the investigating party will review the investigation plan and confirm that the necessary arrangements have been made for conducting the investigation.
The location of the opening meeting will be determined as part of the investigation plan, and may, if appropriate, be hosted by representatives of the appropriate regulatory authorities.
The purpose of this opening meeting is to:
12.2.3.2. Documenting the investigation
The officials conducting the investigation will keep a written record of their findings, together with documentation supplied by the host party representatives. The record will include the locations visited, including farms, and the names and titles of officials interviewed as part of the investigation.
12.2.3.3. Closing meeting
A closing meeting shall be held between representatives of both parties. The location of the meeting will be determined as part of the investigation plan, and may, if appropriate, be hosted by officials of the appropriate regulatory authorities.
The purpose of the meeting is to:
12.2.4. Evaluation
The evaluation should be science based, transparent, and consistent with relevant international standards and with similar evaluations conducted by the importing party.
Depending on the procedures of the importing party, the assessment and/or the report may be made public. Comments on the assessment and/or the report by the exporting party will be governed by existing regulatory requirements of the importing party.
ANNEX VII
FRONTIER CHECKS
The Parties recognise the distinction between documentary, identity and physical checks carried out at external frontiers on imports of live animals and animal products.
The Parties further recognise the need to take a systematic approach to carrying out frontier checks.
Both Parties agree that charges may be made for these checks, in conformity with the relevant provisions of Annex C to the SPS Agreement.
Live animals
The Parties may apply physical checks to all consignments of live animals.
Animal products
In setting their physical checking frequencies for imports of animal products, the Parties shall take due account of the checks applied by the exporting Party prior to export and the historic performance of products imported from the exporting Party.
The Parties may modulate their physical checking frequencies for imports of animal products, notably in the light of progress made toward the recognition of equivalence under the consultative process provided for in Article 7.
ANNEX VIII
OUTSTANDING ISSUES
The Parties agree to work to further develop agreed arrangements concerning frontier checks, including the frequency of physical checks.
The Parties agree to work together on their respective arrangements concerning feed additives, animal feedingstuffs, medicated feeds and premixes.
ANNEX IX
CONTACT POINTS
The USA will send the information provided for in Article 10, and carry out the notifications provided for in Article 11, to:
Agricultural Counsellor
European Union
Delegation of the European Commission to the United States
2300 M Street NW
Washington DC 20037
Tel. 1 202 862 9560
Fax 1 202 429 1766
The Community will send the information provided for in Article 10, and carry out the notifications provided for in Article 11, to:
Agricultural Attaché
Office of Agricultural Affairs
US Mission of the European Union
40 Blvd du Regent
B-1000 Brussels
Tel. 32 2 508 2760
Fax 32 2 511 0918
( 1 ) With very limited exceptions, the USDA/FSIS has sole jurisdiction for these foods until the time they leave the slaughterhouse. After the meat and products have left the slaughterhouse, the USDA/FSIS and the FDA share jurisdiction. The FDA is responsible for the approval of veterinary drugs and food additives in meat and poultry.
( 2 ) See preceding footnote.
( 3 ) The FDA and FSIS share jurisdiction over these products after they have left the processing plant.
( 4 ) These meat products must be made from fresh meat slaughtered under the USDA/FSIS voluntary programme.
( 5 ) Note that the listing of a product in Section II does not mean that certificates will necessarily be required as part of agreements reached on equivalence. Such decisions will be made on a product-by-product basis.
( *1 ) The EC will carry out this commitment in accordance with the procedure laid down in Article 5 of Council Decision 95/408/EC. The USA will carry out this commitment in accordance with a similar timetable.